Full Kits

cGPS CHO-K1 Duo Full Kit

cGPS® (cellular Genome Positioning System) technology based on meganuclease-driven homologous recombination for targeted integration in engineered cell lines. Contains two gene integration sites by combining the advantages of the cGPS CHO-K1 and cGPS Custom CHO-K1 kits. Ideal to develop cell-based assays with difficult to express targets. The Duo product allows working with inducible expression system and expressing multimeric drug targets.

  • 95% of targeted integration events
  • stable expression >12 weeks even in the absence of selection agents
more

cGPS CHO-K1 Duo Full Kit DD

cGPS® (cellular Genome Positioning System) technology based on meganuclease-driven homologous recombination for targeted integration in engineered cell lines. Contains two gene integration sites by combining the advantages of the cGPS CHO-K1 and cGPS Custom CHO-K1 kits. Ideal to develop cell-based assays with difficult to express targets. The Duo product allows working with inducible expression system and expressing multimeric drug targets.

  • 95% of targeted integration events
  • stable expression >12 weeks even in the absence of selection agents
more

cGPS CHO-K1 Full Kit

cGPS® (cellular Genome Positioning System) technology based on meganuclease-driven homologous recombination for targeted integration in engineered cell lines. The cGPS® CHO-K1 Full Kit enables the effortless generation of stable CHO-K1 isogenic clones in 24 days. This kit is ideal for drug screening and drug profiling and has been validated with main drug target classes. Several genes can be co-expressed from the same integration site, from identical or different promoters, allowing for expression level flexibility.

  • Selection of clones in 24 days
  • 98% of targeted integration events
  • stable expression >23 weeks even in the absence of selection agents
more

cGPS CHO-K1 Full Kit DD

cGPS® (cellular Genome Positioning System) technology based on meganuclease-driven homologous recombination for targeted integration in engineered cell lines.
The cGPS® CHO-K1 Full Kit enables the effortless generation of stable CHO-K1 isogenic clones in 24 days. This kit is ideal for drug screening and drug profiling and has been validated with main drug target classes. Several genes can be co-expressed from the same integration site, from identical or different promoters, allowing for expression level flexibility.

  • Selection of clones in 24 days
  • 98% of targeted integration events
  • stable expression >23 weeks even in the absence of selection agents
more